A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-07-14) →
What happened
D&D Pharmatech disclosed a supply contract with Pfizer Inc., worth US$1.24M, about 42.64% of its recent annual revenue, running through Nov 2026.
For context, this single contract equals about 42.64% of the company's most recent annual revenue.
| Counterparty | Pfizer Inc. |
|---|---|
| Contract value | US$1.24M |
| vs. recent revenue | 42.64% |
| Through | Nov 2026 (from Apr 2026) |
| Filed | 2026-04-16, Supply contract signed |
| Source | DART rcept 20260416900081 → open original filing |
Versions of this filing
- 2026-04-16Original (this page)
- 2026-07-14Amendment 1
Source: DART. Information only, not investment advice.